The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 337:1762-1763 December 11, 1997 Number 24
NextNext

Prepublication Release of Journal Articles

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
On July 8, investigators from the Mayo Clinic and Meritcare held a press conference to announce a study of two dozen patients that linked valvular heart disease to a combination of widely used diet pills, fenfluramine and phentermine (fen–phen). The press conference was covered widely by the media. It was not until August 28, more than seven weeks later, that the full report was published in the Journal.1 A press conference to announce the results of a study that had been accepted by the Journal but not yet published was highly unusual. Within several days, we heard from physicians who . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.